CRISPR Therapeutics (NASDAQ:CRSP) General Counsel Sells $148,853.96 in Stock
CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) General Counsel James Kasinger sold 3,182 shares of the firm's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $46.78, for a total value of $148,853.96. Following the transaction, the...